ARF functions as a melanoma tumor suppressor by inducing p53-independent senescence

作者: L. Ha , T. Ichikawa , M. Anver , R. Dickins , S. Lowe

DOI: 10.1073/PNAS.0611638104

关键词:

摘要: Inactivation of the p53 pathway represents most common molecular defect human cancer. But in setting melanoma, a highly aggressive and invariably fatal malignancy its advanced disseminated form, mutation/deletion is relatively rare, whereas positive regulator ARF often lost. Here, we show that genetic deficiency Arf but not facilitates rapid development melanoma genetically engineered mouse model. This difference accounted for, at least part, by unanticipated observation that, unlike fibroblasts, senescence control melanocytes strongly regulated p53. Moreover, oncogenic NRAS collaborates with Arf, p53, to fully transform melanocytes. Our data demonstrate although linked pathway, suppress tumorigenesis through distinct, lineage-dependent mechanisms suggest helps restrict progression executing oncogene-induced program benign nevi. Thus, therapeutics designed restore wild-type function may be insufficient counter other malignancies which holds p53-independent tumor suppressor activity.

参考文章(35)
W.F. Wakeling, E.V. Sviderskaya, D.C. Bennett, A cloned, immortal line of murine melanoblasts inducible to differentiate to melanocytes Development. ,vol. 121, pp. 1547- 1557 ,(1995)
Juan A Recio, Frances P Noonan, Hisashi Takayama, Miriam R Anver, Paul Duray, Walter L Rush, Gerd Lindner, Edward C De Fabo, Ronald A DePinho, Glenn Merlino, None, Ink4a/Arf Deficiency Promotes Ultraviolet Radiation-induced Melanomagenesis Cancer Research. ,vol. 62, pp. 6724- 6730 ,(2002)
Takehiko Kamijo, Frederique Zindy, Martine F. Roussel, Dawn E. Quelle, James R. Downing, Richard A. Ashmun, Gerard Grosveld, Charles J. Sherr, Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF Cell. ,vol. 91, pp. 649- 659 ,(1997) , 10.1016/S0092-8674(00)80452-3
Charles J. Sherr, Divorcing ARF and p53: an unsettled case Nature Reviews Cancer. ,vol. 6, pp. 663- 673 ,(2006) , 10.1038/NRC1954
Yakov Chudnovsky, Amy E Adams, Paul B Robbins, Qun Lin, Paul A Khavari, Use of human tissue to assess the oncogenic activity of melanoma-associated mutations Nature Genetics. ,vol. 37, pp. 745- 749 ,(2005) , 10.1038/NG1586
Ruth Halaban, Rb/E2F: a two-edged sword in the melanocytic system Cancer and Metastasis Reviews. ,vol. 24, pp. 339- 356 ,(2005) , 10.1007/S10555-005-1582-Z
Paul Krimpenfort, Kim C. Quon, Wolter J. Mooi, Ate Loonstra, Anton Berns, Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice. Nature. ,vol. 413, pp. 83- 86 ,(2001) , 10.1038/35092584
Wenge Wang, Farzan Rastinejad, Wafik S El-Deiry, None, Restoring p53-Dependent Tumor Suppression Cancer Biology & Therapy. ,vol. 2, pp. 54- 62 ,(2003) , 10.4161/CBT.203
Norman E Sharpless, Nabeel Bardeesy, Kee-Ho Lee, Daniel Carrasco, Diego H Castrillon, Andrew J Aguirre, Emily A Wu, James W Horner, Ronald A DePinho, None, Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature. ,vol. 413, pp. 86- 91 ,(2001) , 10.1038/35092592
Norman Edward Sharpless, Karuppiah Kannan, Jin Xu, Marcus Wolfram Bosenberg, Lynda Chin, Both products of the mouse INK4a/ARF locus suppress melanoma formation in vivo Oncogene. ,vol. 22, pp. 5055- 5059 ,(2003) , 10.1038/SJ.ONC.1206809